To that end, we conducted ELISA-based measurements of the levels of Ang1, Ang2, IL-6, as well as titers of IgG against the spike protein RBD, in the serum samples of hospitalized COVID-19 patients with various degrees of disease severity. This evidence concerns the gene IL6 and COVID-19.